06978 永泰生物－Ｂ
按盤價 
2.500 +0.160 (+6.838%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 資產回報率 (%) | -38.803% | -32.179% | -30.696% | -53.963% | -31.256% |
| 股東資金回報率 (%) | -98.180% | -47.811% | -36.334% | -67.729% | -56.727% |
| 資本運用回報率 (%) | -52.084% | -47.411% | -38.604% | -37.251% | -51.613% |
邊際利潤分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | N/A | N/A | N/A | N/A | N/A |
| 未計利息、稅項、折舊及攤銷前利潤率 (%) | N/A | N/A | N/A | N/A | N/A |
| 稅前邊際利潤率 (%) | N/A | N/A | N/A | N/A | N/A |
| 純利率 (%) | N/A | N/A | N/A | N/A | N/A |
變現能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流動比率 (X) | 1.051 X | 0.567 X | 2.289 X | 27.951 X | 1.495 X |
| 速動比率 (X) | 1.051 X | 0.567 X | 2.289 X | 27.951 X | 1.471 X |
財務槓桿分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 總負債 / 總資產比率 (%) | 79.807% | 42.421% | 25.008% | 6.724% | 59.149% |
| 總債項 / 總資產比率 (%) | 54.021% | 17.034% | 10.117% | 4.219% | 9.353% |
| 淨債項 / 總資產比率 (%) | 47.858% | 10.388% | -22.072% | -65.634% | -58.337% |
| 總債項 / 股東資金比率 (%) | 263.324% | 29.464% | 13.506% | 4.528% | 23.085% |
| 長期債項 / 股東資金比率 (%) | 249.110% | 24.339% | 11.048% | 3.890% | 20.844% |
| 淨債項 / 股東資金比率 (%) | 233.280% | 17.968% | -29.466% | -70.448% | -143.983% |
| 淨現金 / (債項) ($) | (4.05億) | (9.14千萬) | 2.42億 | 7.94億 | 2.43億 |
| 每股淨現金 / (債項) ($) | (0.787) | (0.178) | 0.471 | 1.544 | -- |
| 總債項 / 資本運用比率 (%) | 71.117% | 22.327% | 12.103% | 4.332% | 18.501% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
營運效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存貨周轉率日數 (日) | N/A | N/A | N/A | N/A | -- |
| 應收貿易帳周轉率日數 (日) | N/A | N/A | N/A | N/A | N/A |
| 應付貿易帳周轉率日數 (日) | N/A | N/A | N/A | N/A | N/A |
| 備註： | 即時報價更新時間為23/12/2024 10:40 |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
| 股東應佔溢利/(虧損) () | RMB -92,515,000 |
| 增長率 | -21.673% |
| 每股盈利/(虧損) | RMB -0.180 |
| 每股帳面資產淨值 (¥) | RMB 0.158 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
